PROTEOMICS · 2003 · 115 citations · 9 references
Life SciencesBiochemistryOncologyProteomicsRenal PathologyUrologic OncologyCancer BiomarkersCancer ProteomicsClinical ProteomicsProtein IdentificationProteomic BiomarkersUrologic Cancer DiagnosisC4.5 AlgorithmCancer Proteome ProfilingEarly DiagnosisKidney Cancer DiagnosisProteomic Data AnalysisRenal Cell Carcinoma BiomarkersTime-of-flight Mass SpectrometryTumor Proteomics
Despite having a relatively low incidence, renal cell carcinoma (RCC) is one of the most lethal urologic cancers. For successful treatment including surgery, early detection is essential. Currently there is no screening method such as biomarker assays for early diagnosis of RCC. Surface-enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF) is a recent technical advance that can be used to identify biomarkers for cancers. In this study, we investigated whether SELDI protein profiling and artificial intelligence analysis of serum could distinguish RCC from healthy persons and other urologic diseases (nonRCC). The SELDI-TOF data was acquired from a total of 36 serum samples with weak cation exchange-2 protein chip arrays and filtered using ProteinChip software. We used a decision tree algorithm c4.5 to classify the three groups of sera. Five proteins were identified with masses of 3900, 4107, 4153, 5352, and 5987 Da. These biomarkers can correctly separate RCC from healthy and nonRCC samples.
9
Use of proteomic patterns in serum to identify ovarian cancer
Emanuel F. Petricoin, Ali M. Ardekani, Ben A. Hitt et al. · The Lancet · 2002 · 3.3K citations
Medicine, Gynecology, Oncology +17
Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1999 · 3.1K citations · Full text
Medicine, Biostatistics, Oncology +17
Learning logical definitions from relations
J. R. Quinlan · Machine Learning · 1990 · 616 citations · Full text
GL Wright, SM Leung, Suhail Nasim et al. · Prostate Cancer and Prostatic Diseases · 1999 · 262 citations